Nuvectis Pharma (NVCT) Preferred Shares Issued (2021)

Nuvectis Pharma's (NVCT) quarterly Preferred Shares Issued came in at $4.0 million in Q3 2021.

Nuvectis Pharma (NVCT) Preferred Shares Issued (2021) Analysis & Trends

Nuvectis Pharma has disclosed Preferred Shares Issued across 1 years of filings, most recently posting $4.0 million for Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares Issued (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn -
9 Abivax 91.71 Bn 91.71 Bn - -
10 Nuvectis Pharma 274.90 Mn 274.90 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2021 4.02 Mn
Sep 30, 2021 4.02 Mn